Nora Dimon

Nora Dimon, MD, serves as the Executive Director of Clinical Development at ADARx Pharmaceuticals Inc. since July 2025 and holds dual roles as an Adjunct and Visiting Retina Specialist at Massachusetts Eye and Ear from January 2023. Additionally, Nora is the Senior Director of Clinical Development at Ocular Therapeutix, Inc. from 2024. Prior experience includes serving as the Strategic Head of Clinical Development for Retina Health at Boehringer Ingelheim from January 2022 to January 2024, and as Medical Director of Clinical Development & Medical Affairs at Ocugen in 2021. Previous roles also encompass positions at King's College London and SEED LLC, where Nora co-founded and acted as Chief Medical Officer. Educational background includes a Doctor of Medicine from The University of Freiburg, with additional training at Yale School of Medicine, Fudan University, and the University of Nottingham, where Nora completed a PhD in Pre-Clinical Oncology and Genetics.